Market Cap 3.27B
Revenue (ttm) 0.00
Net Income (ttm) -175.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 925,000
Avg Vol 1,393,774
Day's Range N/A - N/A
Shares Out 45.86M
Stochastic %K 85%
Beta -2.29
Analysts Strong Sell
Price Target $99.12

Latest News on SLNO

Soleno Therapeutics Announces VYKAT(TM) XR Launch

Apr 14, 2025, 7:00 AM EDT - 10 days ago

Soleno Therapeutics Announces VYKAT(TM) XR Launch


SLNO Stock Rises as Prader-Willi Treatment Nears FDA Approval

Oct 8, 2024, 6:51 PM EDT - 7 months ago

SLNO Stock Rises as Prader-Willi Treatment Nears FDA Approval


Soleno Therapeutics: Impressive Data, But Never Forget Amarin

Nov 26, 2023, 10:47 AM EST - 1 year ago

Soleno Therapeutics: Impressive Data, But Never Forget Amarin


Soleno Stock Dives After Its Meteoric Rise

Sep 27, 2023, 1:28 PM EDT - 1 year ago

Soleno Stock Dives After Its Meteoric Rise